Genmab A (GMAB) FCF Margin (2023 - 2026)

Genmab A (GMAB) has reported FCF Margin for 4 consecutive years, with 4.42% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, FCF Margin fell 1552.0% year-over-year to 4.42%; the trailing twelve-month figure through Jun 2026 stood at 19.93% (down 1008.0% YoY), and the FY2025 full-year result was 30.89%, up 8277.0% from the prior year.
• FCF Margin climbed to 4.42% in Q2 2026 per GMAB's latest filing, from 0.33% in the prior quarter.
• Across five years, FCF Margin topped out at 49.3% in Q4 2023 and bottomed at 0.33% in Q1 2026.
• Historically, FCF Margin has averaged 27.59% across 4 years, with a median of 33.25% in 2025.
• The sharpest annual moves came in 2025 and 2026: FCF Margin soared 382 bps in 2025, then tumbled 3981 bps in 2026.
• Over 4 years, FCF Margin stood at 49.3% in 2023, then sank by 32 bps to 33.53% in 2024, then retreated by 1 bps to 33.25% in 2025, then sank by 87 bps to 4.42% in 2026.
• According to Business Quant data, FCF Margin over the past three periods registered 4.42%, 0.33%, and 33.25% for Q2 2026, Q1 2026, and Q3 2025 respectively.